Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Escalating Clopidogrel by Involving a Genetic Strategy - Thrombolysis In Myocardial Infarction 56 (ELEVATE-TIMI56)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2011 by The TIMI Study Group.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborators:
Bristol-Myers Squibb
Sanofi
Information provided by:
The TIMI Study Group
ClinicalTrials.gov Identifier:
NCT01235351
First received: November 2, 2010
Last updated: October 4, 2011
Last verified: October 2011